Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage

• Status: Completed
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

Post partum Hemorrhage (PPH) is one of three main causes of death in pregnant women. Oxytocin is widely used for prevention of PPH. Some studies suggested misoprostol as an alternative treatment when Oxytocin isn't available. The aim of this study is to compare the safety and efficacy of Oxytocin and misoprostol for prevention of PPH.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hormozgan University of Medical Sciences
• Treatments: Misoprostol; Oxytocin

Criteria

Inclusion Criteria:

• were women with singleton pregnancy

• with cephalic presentation

• who had NVD spontaneously or by induction

Exclusion Criteria:

• placenta previa

• placental detachment

• coagulation problems

• previous CS

• macrosomia

• Polyhydramnios

• and uncontrolled asthma